Methotrexate Sodium

CAS 7413-34-5 5 current records 2 historicalSmall Molecule

Who holds supplier records for Methotrexate Sodium? 5 organisations hold a current record for Methotrexate Sodium: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3), Germany (1) and Finland (1).

Most records are filed under another form of this substance: Methotrexate (9 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Methotrexate Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/methotrexate-sodium

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Methotrexate Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Methotrexate Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Methotrexate Sodium are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • HEINRICH MACK NACHFOLGER
    Inactive DMF 10863 · filed Apr 1994
  • LACHEMA BRNO
    Inactive DMF 9526 · filed Jan 1992

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Methotrexate sodium is a folate analog metabolic inhibitor that exerts its antineoplastic and immunosuppressive properties by inhibiting the enzyme dihydrofolate reductase, interfering with DNA synthesis, repair, and cellular replication. It is used in the treatment of various types of cancer and autoimmune diseases such as rheumatoid arthritis.

Chemical identity

IUPAC name
disodium;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioate
Canonical SMILES
CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]
InChIKey
FBOZXECLQNJBKD-ZCXUNETKSA-M
Synonyms
MTX

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Folate Analog Metabolic Inhibitor
Mechanism of action
Folic Acid Metabolism Inhibitors

Therapeutic areas

OncologyRheumatologyDermatology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Methotrexate Sodium?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Methotrexate Sodium: Alembic Pharmaceuticals Limited (India), EXCELLA GMBH AND CO KG (Germany), FERMION OY (Finland), MSN Laboratories Private Limited (India) and SHILPA PHARMA LIFESCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Methotrexate Sodium Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 36277), EXCELLA GMBH AND CO KG (DMF 12472), FERMION OY (DMF 23532), MSN Laboratories Private Limited (DMF 42627) and SHILPA PHARMA LIFESCIENCES LTD (DMF 42795). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Methotrexate Sodium records mean?

2 organisations have only inactive Type II DMFs for Methotrexate Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Methotrexate Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Methotrexate Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.